CCL2 and neoplasm: The fact that MC38 mouse CRC cells grow readily as discrete tumors in syngeneic C57BL/6 mice allowed us to determine whether EPA treatment was associated with lower CCL2 expression in vivo, albeit with the similar proviso to human CRCLMs that paired pre- and post-treatment levels from the same tumor were unavailable.